72.16
Schlusskurs vom Vortag:
$71.22
Offen:
$71.68
24-Stunden-Volumen:
296.35K
Relative Volume:
0.56
Marktkapitalisierung:
$4.00B
Einnahmen:
$76.81M
Nettoeinkommen (Verlust:
$-162.42M
KGV:
-24.13
EPS:
-2.99
Netto-Cashflow:
$-122.49M
1W Leistung:
+2.72%
1M Leistung:
+0.11%
6M Leistung:
+9.95%
1J Leistung:
+10.24%
Arcellx Inc Stock (ACLX) Company Profile
Firmenname
Arcellx Inc
Sektor
Branche
Telefon
240-327-0603
Adresse
800 BRIDGE PARKWAY, REDWOOD CITY
Vergleichen Sie ACLX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
ACLX
Arcellx Inc
|
72.16 | 3.87B | 76.81M | -162.42M | -122.49M | -2.99 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Arcellx Inc Stock (ACLX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-06-17 | Eingeleitet | Citigroup | Buy |
2024-10-08 | Eingeleitet | Redburn Atlantic | Buy |
2024-09-03 | Eingeleitet | Cantor Fitzgerald | Overweight |
2024-05-31 | Eingeleitet | Piper Sandler | Overweight |
2024-03-07 | Eingeleitet | Morgan Stanley | Overweight |
2024-01-04 | Bestätigt | Needham | Buy |
2023-12-19 | Eingeleitet | Scotiabank | Sector Outperform |
2023-10-30 | Eingeleitet | TD Cowen | Outperform |
2023-10-17 | Eingeleitet | UBS | Buy |
2023-05-18 | Eingeleitet | Truist | Buy |
2023-04-14 | Eingeleitet | Robert W. Baird | Outperform |
2023-03-14 | Eingeleitet | Stifel | Buy |
2023-02-13 | Eingeleitet | H.C. Wainwright | Buy |
2022-12-13 | Fortgesetzt | BofA Securities | Buy |
2022-10-31 | Eingeleitet | Guggenheim | Buy |
2022-10-27 | Eingeleitet | Needham | Buy |
2022-07-20 | Eingeleitet | Canaccord Genuity | Buy |
2022-03-01 | Eingeleitet | BofA Securities | Buy |
2022-03-01 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Arcellx Inc Aktie (ACLX) Neueste Nachrichten
Cell Therapy Pioneer Arcellx to Showcase Innovation at Morgan Stanley Healthcare Conference 2025 - Stock Titan
Is Arcellx Inc. stock reversal real or fakeJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - Newser
Using data tools to time your Arcellx Inc. exitMarket Sentiment Report & Community Trade Idea Sharing Platform - Newser
How cyclical is Arcellx Inc.’s revenue streamJuly 2025 Intraday Action & Reliable Breakout Stock Forecasts - khodrobank.com
Short interest data insights for Arcellx Inc.July 2025 Catalysts & Real-Time Market Trend Scan - Newser
Using economic indicators to assess Arcellx Inc. potentialWeekly Profit Report & Daily Chart Pattern Signals - Newser
Will breakout in Arcellx Inc. lead to full recoveryTrade Exit Report & Weekly Stock Breakout Alerts - Newser
Published on: 2025-09-03 04:03:42 - Newser
Applying sector rotation models to Arcellx Inc.Weekly Stock Recap & Low Risk Entry Point Guides - Newser
When is the best time to exit Arcellx Inc.July 2025 Patterns & Risk Controlled Stock Pick Alerts - Newser
Using R and stats models for Arcellx Inc. forecastingTrade Volume Report & Daily Technical Stock Forecast Reports - Newser
Is Arcellx Inc. in a bullish channelWeekly Gains Report & Risk Managed Investment Entry Signals - khodrobank.com
Real time scanner hits for Arcellx Inc. explained2025 Retail Activity & Verified Entry Point Signals - Newser
Tick level data insight on Arcellx Inc. volatilityOptions Play & Long-Term Investment Growth Plans - Newser
Arcellx Inc. stock trend outlook and recovery pathJuly 2025 Levels & Technical Entry and Exit Tips - Newser
Is now the right time to enter Arcellx Inc.Day Trade & Verified Technical Trade Signals - khodrobank.com
Intraday pattern recognizer results for Arcellx Inc.2025 AllTime Highs & Smart Allocation Stock Tips - Newser
Exit strategy if you’re trapped in Arcellx Inc.Analyst Upgrade & Free High Accuracy Swing Entry Alerts - Newser
Using Bollinger Bands to evaluate Arcellx Inc.Quarterly Profit Report & Real-Time Volume Analysis Alerts - Newser
Strategies to average down on Arcellx Inc.Weekly Trend Recap & Expert Curated Trade Setup Alerts - Newser
Real time pattern detection on Arcellx Inc. stock2025 Volume Leaders & Technical Analysis for Trade Confirmation - Newser
Is Arcellx Inc. stock a buy or sellJuly 2025 Momentum & Reliable Entry Point Alerts - khodrobank.com
Arcellx Inc. stock daily chart insights2025 Technical Overview & Reliable Breakout Forecasts - Newser
How to build a dashboard for Arcellx Inc. stockJuly 2025 EndofMonth & Community Consensus Stock Picks - Newser
Applying big data sentiment scoring on Arcellx Inc.July 2025 Price Swings & Breakout Confirmation Alerts - Newser
Arcellx Inc. stock volume spike explained2025 Volume Leaders & Weekly Momentum Picks - Newser
How high can Arcellx Inc. stock goCEO Change & Low Risk High Win Rate Stock Picks - Newser
How to use a screener to detect Arcellx Inc. breakoutsJuly 2025 Patterns & AI Forecast Swing Trade Picks - Newser
Developing predictive dashboards with Arcellx Inc. dataPortfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - Newser
Real time breakdown of Arcellx Inc. stock performanceTrade Volume Summary & Safe Entry Zone Tips - Newser
Visual trend scoring systems applied to Arcellx Inc.Index Update & Weekly Stock Performance Updates - Newser
How to monitor Arcellx Inc. with trend dashboardsRisk Management & Precise Buy Zone Tips - Newser
Is Arcellx Inc. still worth holding after the dip2025 Market Trends & Detailed Earnings Play Alerts - Newser
Can Traders Expect Breakout From Arcellx Inc. This Week getLinesFromResByArray error: size == 0 - kangso.co.kr
Heatmap analysis for Arcellx Inc. and competitorsPortfolio Gains Summary & Free Safe Entry Trade Signal Reports - Newser
Will Arcellx Inc. price bounce be sustainableMarket Risk Summary & Daily Profit Focused Screening - Newser
Finanzdaten der Arcellx Inc-Aktie (ACLX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Arcellx Inc-Aktie (ACLX) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Patel Kavita | Director |
Jun 10 '25 |
Sale |
67.36 |
1,500 |
101,040 |
0 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):